The Journal of Immunology, Vol 155, Issue 3 1110-1116, Copyright © 1995 by American Association of Immunologists

ARTICLES

Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells

M Komai-Koma, FY Liew and PC Wilkinson
Department of Immunology, University of Glasgow Western Infirmary, United Kingdom.

The locomotor properties of small, surface IgM+ and surface IgD+ B cells from the human tonsil were studied using polarization assays and collagen gel invasion assays. These cells gave poor locomotor responses when freshly isolated from the tonsil; but 30 to 40% of the cells polarized and invaded collagen gels after overnight culture in IL-4 or anti-CD40. IL-13 had a similar but weaker effect. Culture with anti- CD40 and IL-4 together gave a higher proportion of polarized cells than either alone, and culture in anti-CD40, IL-4, and anti-IgM gave a still higher proportion (> 60% of B cells polarized). Polarization increased gradually, during hours of culture, unlike the typical rapid response to chemoattractants. We also studied the immediate (< 30 min) effects of chemoattractants on B cell polarization. B cells cultured overnight then washed, but not B cells fresh from the tonsil, polarized immediately in response to anti-CD40. Similar responses to anti-IgM and anti-IgD, both pre- and postculture were also observed, but the response of cultured cells was stronger. IL-4-cultured B cells invaded collagen gels incorporating anti-IgM, anti-IgD, or anti-CD40 in higher numbers than control gels. Most of the invading cells were surface IgM+. These results suggest that locomotor activation in B cells requires two steps. The capacity for locomotion is growth-related and is first activated by IL-4 or by anti-CD40, enhanced by the presence of anti-IgM. Following activation, the cells respond rapidly to chemoattractants such as anti-Ig or anti-CD40.

This article has been cited by other articles:

				D. Cai, K. N. Felekkis, R. I. Near, G. M. O'Neill, J. M. van Seventer, E. A. Golemis, and A. Lerner The GDP Exchange Factor AND-34 Is Expressed in B Cells, Associates With HEF1, and Activates Cdc42 J. Immunol., January 15, 2003; 170(2): 969 - 978. [Abstract] [Full Text] [PDF]

				M. Komai-Koma, J. A. Gracie, X.-q. Wei, D. Xu, N. Thomson, I. B. McInnes, and F. Y. Liew Chemoattraction of Human T Cells by IL-18 J. Immunol., January 15, 2003; 170(2): 1084 - 1090. [Abstract] [Full Text] [PDF]

				L. Westerberg, G. Greicius, S. B. Snapper, P. Aspenstrom, and E. Severinson Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes Blood, August 15, 2001; 98(4): 1086 - 1094. [Abstract] [Full Text] [PDF]

				E. J. Davey, G. Greicius, J. Thyberg, and E. Severinson STAT6 is required for the regulation of IL-4-induced cytoskeletal events in B cells Int. Immunol., July 1, 2000; 12(7): 995 - 1003. [Abstract] [Full Text] [PDF]

				A. Corcione, L. Ottonello, G. Tortolina, P. Facchetti, I. Airoldi, R. Guglielmino, P. Dadati, M. Truini, S. Sozzani, F. Dallegri, et al. Stromal Cell-Derived Factor-1 as a Chemoattractant for Follicular Center Lymphoma B Cells J Natl Cancer Inst, April 19, 2000; 92(8): 628 - 635. [Abstract] [Full Text] [PDF]

				J. W. Baird, R. J. B. Nibbs, M. Komai-Koma, J. A. Connolly, K. Ottersbach, I. Clark-Lewis, F. Y. Liew, and G. J. Graham ESkine, a Novel beta -Chemokine, Is Differentially Spliced to Produce Secretable and Nuclear Targeted Isoforms J. Biol. Chem., November 19, 1999; 274(47): 33496 - 33503. [Abstract] [Full Text] [PDF]

				L. Ottonello, A. Corcione, G. Tortolina, I. Airoldi, E. Albesiano, A. Favre, R. D'Agostino, F. Malavasi, V. Pistoia, and F. Dallegri rC5a Directs the In Vitro Migration of Human Memory and Naive Tonsillar B Lymphocytes: Implications for B Cell Trafficking in Secondary Lymphoid Tissues J. Immunol., June 1, 1999; 162(11): 6510 - 6517. [Abstract] [Full Text] [PDF]

				E. J. Davey, J. Thyberg, D. H. Conrad, and E. Severinson Regulation of Cell Morphology in B Lymphocytes by IL-4: Evidence for Induced Cytoskeletal Changes J. Immunol., June 1, 1998; 160(11): 5366 - 5373. [Abstract] [Full Text] [PDF]

				A. Corcione, L. Ottonello, G. Tortolina, P. Tasso, F. Ghiotto, I. Airoldi, G. Taborelli, F. Malavasi, F. Dallegri, and V. Pistoia Recombinant Tumor Necrosis Factor Enhances the Locomotion of Memory and Naive B Lymphocytes From Human Tonsils Through the Selective Engagement of the Type II Receptor Blood, December 1, 1997; 90(11): 4493 - 4501. [Abstract] [Full Text] [PDF]